Novo Nordisk
NVO
#21
Rank
โ‚ฌ436.12 B
Marketcap
100,04ย โ‚ฌ
Share price
-0.40%
Change (1 day)
5.93%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ49.62 Billion

According to Novo Nordisk's latest financial reports the company's total assets are โ‚ฌ49.62 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ42.13 B30.08%
2022-12-31โ‚ฌ32.38 B23.86%
2021-12-31โ‚ฌ26.14 B34.26%
2020-12-31โ‚ฌ19.47 B15.85%
2019-12-31โ‚ฌ16.81 B13.33%
2018-12-31โ‚ฌ14.83 B7.87%
2017-12-31โ‚ฌ13.75 B4.74%
2016-12-31โ‚ฌ13.12 B6.71%
2015-12-31โ‚ฌ12.30 B18.89%
2014-12-31โ‚ฌ10.34 B9.75%
2013-12-31โ‚ฌ9.42 B7.12%
2012-12-31โ‚ฌ8.80 B1.43%
2011-12-31โ‚ฌ8.67 B5.35%
2010-12-31โ‚ฌ8.23 B11.93%
2009-12-31โ‚ฌ7.36 B8.02%
2008-12-31โ‚ฌ6.81 B6.36%
2007-12-31โ‚ฌ6.40 B6.66%
2006-12-31โ‚ฌ6.00 B7.26%
2005-12-31โ‚ฌ5.59 B10.7%
2004-12-31โ‚ฌ5.05 B9.19%
2003-12-31โ‚ฌ4.63 B5.51%
2002-12-31โ‚ฌ4.39 B-7.83%
2001-12-31โ‚ฌ4.76 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ201.75 B 306.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ70.55 B 42.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ87.41 B 76.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ129.80 B 161.59%๐Ÿ‡ซ๐Ÿ‡ท France